Figure S8 from The TOPK Inhibitor HI-TOPK-032 Enhances CAR T-cell Therapy of Hepatocellular Carcinoma by Upregulating Memory T Cells
crossref（2024）
摘要
Activation of mTOR diminishes the effects of HI-TOPK-032 on GPC3-CAR-T therapy and reduces CD8+ TCM frequency in tumor-bearing mice.
查看译文
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要